Veterinary Blog

Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates

Featuring

Dr. Gerry Post, The Internet

Dr. Cheryl London, DVM, PhD, Diplomate ACVIM (Oncology)

Veterinary Targeted Therapies in the Time of COVID-19, Part 1

Dr. London is a global leader in veterinary targeted therapies. She discusses potential risks to veterinary staff, the value of targeted therapy in times of constrained PPE resources, and the effects of COVID-19 on research activity.

Webinars

Dr. Gerry Post,

The Internet

Dr. Nicola Mason,

B.Vet.Med, PhD, DACVIM (Internal Medicine)

Personalized Medicine: Because Not All Tumors Are Created Equally

Dr. Gerry Post,

The Internet

Dr. Carrie Jurney,

DVM, DACVIM (Neurology), President  of Not One More Vet

Mental Health in the Veterinary Community in the Age of COVID-19

Dr. Gerry Post,

The Internet

Dr Barbara Kitchell,

DVM, DACVIM (Oncology)

Repurposed (Human and Animal) Drugs Amidst the COVID-19 Pandemic

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Dr. Gerry Post

Aug 2 • 2 min read

Medical Brief: Histiocytic Sarcoma

Dr. Lucas Rodrigues

Jul 26 • 7 min read

Data

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

Dr. Gerry Post

Jul 12 • 1 min read

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Sarah Mills

Jun 30 • 5 min read

Win-Win -The Development of Novel Immunotherapies for Brain Tumors Using Pet Dogs

Dr. Gerry Post

Jun 11 • 32 min read

Webinars

Medical Brief:The Median Isn’t the Message

Dr. Gerry Post

Jun 11 • 3 min read

Medical Brief: Melanoma Understanding the DNA Mutation Landscape

Dr. Lucas Rodrigues

May 13 • 11 min read

Data

The Path Ahead for Combination Therapy Approaches to Canine Cancer Treatment

Dr. Gerry Post

May 4 • 21 min read

Webinars

World Veterinary Day

Dr. Gerry Post

Apr 23 • 10 min read

Medical Brief: Sorafenib in Dogs

Dr. Gerry Post

Apr 22 • 2 min read

Recent articles

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Medical Brief: Histiocytic Sarcoma

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Topics

Veterinary Blog

Veterinary Targeted Therapies in the Time of COVID-19, Part 1

Webinars

Personalized Medicine: Because Not All Tumors Are Created Equally

Mental Health in the Veterinary Community in the Age of COVID-19

Repurposed (Human and Animal) Drugs Amidst the COVID-19 Pandemic

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Medical Brief: Histiocytic Sarcoma

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Win-Win -The Development of Novel Immunotherapies for Brain Tumors Using Pet Dogs

Medical Brief:The Median Isn’t the Message

Medical Brief: Melanoma Understanding the DNA Mutation Landscape

The Path Ahead for Combination Therapy Approaches to Canine Cancer Treatment

World Veterinary Day

Medical Brief: Sorafenib in Dogs

Discover more content...

Results

We're sorry!

Recent articles

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Medical Brief: Histiocytic Sarcoma

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Topics